Table 2 Prediction for infection
Crude | Adjusted | |||
|---|---|---|---|---|
sHRa(95%C.I.) | p-value | sHRa(95%C.I.) | p-value | |
Cancer vs. Non-cancer | 0.92 (0.64–1.32) | 0.6374 | 0.91 (0.63–1.31) | 0.6089 |
Comorbidities | ||||
Myocardial infarct | 1.58 (0.74–3.36) | 0.2355 | 1.47 (0.68–3.18) | 0.3334 |
congestive heart failure | 1.18 (0.77–1.79) | 0.4473 | 1.07 (0.70–1.64) | 0.7466 |
peripheral vascular | 1.42 (0.73–2.78) | 0.3036 | 1.33 (0.68–2.63) | 0.4084 |
cerebrovascular disease | 1.22 (0.87–1.69) | 0.2500 | 1.08 (0.76–1.53) | 0.6857 |
dementia | 1.79 (0.92–3.51) | 0.0874 | 1.63 (0.82–3.24) | 0.1631 |
chronic lung disease | 1.17 (0.88–1.55) | 0.2827 | 1.11 (0.82–1.50) | 0.4975 |
connective tissue disease | 1.06 (0.63–1.80) | 0.8218 | 1.05 (0.62–1.78) | 0.8579 |
Ulcer | 1.10 (0.83–1.46) | 0.5153 | 1.03 (0.77–1.38) | 0.8437 |
chronic liver disease | 1.09 (0.75–1.59) | 0.6491 | 1.07 (0.73–1.57) | 0.7438 |
Diabetes | 1.14 (0.84–1.54) | 0.4175 | 0.99 (0.71–1.40) | 0.9698 |
diabetes with end organ damage | 1.77 (1.03–3.06) | 0.0401 | 1.67 (0.91–3.06) | 0.1007 |
Hemiplegia | 1.52 (0.48–4.80) | 0.4733 | 1.28 (0.40–4.12) | 0.6779 |
moderate or severe kidney disease | 1.12 (0.67–1.87) | 0.6631 | 1.07 (0.64–1.79) | 0.7902 |
Moderate or severe liver disease | – | – | ||
AIDS | .- | – | ||
Chemotherapy | 0.96 (0.54–1.72) | 0.8913 | 0.99 (0.47–2.09) | 0.9815 |
Metastasis | 8.66 (1.24–60.50) | 0.0296 | 10.13 (1.19–86.34) | 0.0343 |